ClinicalTrials.gg
Status unknownNCT05518890Updated Aug 29, 2022

Effect of Energy Restriction and Exercise for Knee Osteoarthritis

An interventional study of Diet Only and Diet plus Exercise in Knee Osteoarthritis, sponsored by University of Bath. Status unknown at 1 site in United Kingdom. Open to participants aged 45 Years to 69 Years. Per ClinicalTrials.gov, last updated 2022-08-29.

Sponsored by University of Bath · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
45 Years to 69 Years
Sex
All
01

Study summary

The investigators are looking at the effects of energy restriction, with or without exercise on markers of inflammation in individuals with knee osteoarthritis. There will be a 4 week 'wash-in' period where participants will maintain their normal lifestyle, followed by a 4 week 'intervention period' where participants will be randomised into either the diet alone group or the diet plus exercise group.

Read the detailed description

Knee Osteoarthritis is a condition that causes pain, reduced physical function and quality of life. Long-term studies have shown that exercise and substantial weight loss can cause improvements in these factors. Individuals with knee Osteoarthritis might have changes in their joint that can be seen with x-ray images. However, this is not guaranteed, and imaging does not always detect changes that occur with interventions that cause improved symptoms. As a result, there is interest in biological markers (biomarkers) as another way of monitoring Osteoarthritis. These markers can be examined in biological tissues, with samples measured in blood easier to obtain than those taken from the fluid within the joint itself. Historically, Osteoarthritis was thought of as a disease caused by mechanical factors but we are now aware that inflammation also plays a part.

Therefore, the investigators aim to test a short -term diet/exercise intervention that has been show to improve inflammation in other populations, in individuals with knee osteoarthritis. Importantly, this will allow the investigators to see if reducing food intake alone or doing this with regular exercise can improve outcomes without substantial weight loss. The investigators will ask individuals to participate in one of two groups where they will first be asked to continue their normal lifestyle for 4 weeks to check the stability of outcomes. The investigators will then ask individuals to either reduce their food intake by 5000 calories per week, or do this while also completing moderate intensity cycling exercise 5 times a week for 4 weeks. At the start and end of each period the investigators will collect a blood sample to assess markers of inflammation and disease related processes. The investigators will also conduct questionnaire measurements, tests of physical function and experimental pain and scan participants to establish body composition.

02

Conditions studied

  • Knee Osteoarthritis
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's planned enrollment of 32 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

University of Bath is the lead sponsor of 94 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or post-menopausal females
  • Clinically diagnosed with knee Osteoarthritis including radiographic confirmation
  • Oxford Knee Score ≥20 to ≤35 for index knee
  • Aged 45-69 years
  • BMI ≥27.5kg/m2 to ≤40.0 kg/m2
  • Daily physical activity level \<2.00

Exclusion criteria

Exclusion Criteria:

  • Inability to undertake cycling exercise safely
  • Use of prescribed anti-inflammatory medication
  • Current smoker (or having quit \<6months ago)
  • Has a diagnosis of diabetes or other metabolic disorder
  • Use of other medications that might interfere with study outcomes
  • Recent (within last 3 months) change in body mass of >5%
  • Currently engaged in an ongoing programme of physiotherapy treatment
  • Currently on waiting list or having had surgery for Osteoarthritis on the index knee (prior OA related surgery permitted on other knee as long as this is greater than 12 months prior to enrolment)
  • Having had major hip/knee surgery within preceding 12 months
  • Individuals with a blood pressure of greater than 180/110
  • Currently pregnant or intending to become pregnant during the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Diet Only

    Reduced calorie intake by 5000kcals per week over a 4 week period

    Other: Diet Only

  • Experimental
    Diet plus Exercise

    Reduced calorie intake by 5000kcals per week over 4 weeks with the addition of five 30 minute exercise sessions per week on a cycle ergometer. The exercise in intensity will be progressive and perceptually based and monitored by the investigators.

    Other: Diet plus Exercise

Interventions

  • OtherDiet Only

    Participants caloric intake will be reduced by 5000kcal per week over 4 weeks

  • OtherDiet plus Exercise

    Participants caloric intake will be reduced by 5000kcal per week over 4 weeks. Participants will also be asked to perform 5x30 minute cycling exercise sessions at home. Each week the intensity of exercise will be increased (week 1 = RPE 12, week 2 = RPE 13, week 3 = RPE 14, week 4 = RPE 15)

06

What researchers measure

Primary outcomes

  1. Change in hsCRP

    Measured in mg/L via immunoassay

    Time frame: 0, 4 and 8 weeks

Secondary outcomes

  1. Other Systemic Biomarkers

    Measured in pg/ml via electrochemiluminescence * Interleukin-1 Beta * Interleukin-1Receptor Antagonist * Interleukin- 4 * Interleukin- 6 * Interleukin- 8 * Interleukin- 10 * Interleukin- 13 * Interleukin-17A * Interleukin-18 * Tumor Necrosis Factor- alpha

    Time frame: 0, 4 and 8 weeks

  2. The Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Pain, Symptoms, Activity of daily living, Sport/Rec, Quality of Life subscales. Each subscale has a minimum score of 0% and a maximum score of 100%, with lower values representing worse outcomes.

    Time frame: 0, 4 and 8 weeks

  3. EQ-5D-5L Health Questionnaire

    Mobility, Self-care, Usual activities, Pain/discomfort and Anxiety/depression. Each of the five dimensions comprising the EQ-5D descriptive system is divided into five levels of perceived problems: LEVEL 1: indicating no problem LEVEL 2: indicating slight problems LEVEL 3: indicating moderate problems LEVEL 4: indicating severe problems LEVEL 5: indicating unable to/extreme problems A unique health state is defined by combining one level from each of the five dimensions.

    Time frame: 0, 4 and 8 weeks

  4. SF-36 Questionnaire

    Physical functioning, Bodily pain, Role limitations due to physical health problems, Role limitations due to personal or emotional problems, Emotional well-being, Social functioning, Energy/fatigue, and General health perceptions. Scores for each domain range from 0 to 100, with a higher score defining a more favourable health state.

    Time frame: 0, 4 and 8 weeks

  5. Visual Analogue Scale (VAS) Pain

    0-10 scale Higher scores indicate worse pain

    Time frame: 0, 4 and 8 weeks

  6. 30-second chair stand test

    Repetitions

    Time frame: 0, 4 and 8 weeks

  7. 40m fast paced walk

    meters/second

    Time frame: 0, 4 and 8 weeks

  8. Stair climb

    seconds

    Time frame: 0, 4 and 8 weeks

  9. Timed up and go test

    seconds

    Time frame: 0, 4 and 8 weeks

  10. Mechanical Detection Threshold

    millinewtons (mN)

    Time frame: 0, 4 and 8 weeks

  11. Pressure Pain Threshold

    Newtons (N)

    Time frame: 0, 4 and 8 weeks

  12. Body Mass Index

    kg/m2

    Time frame: 0, 4 and 8 weeks

  13. Hip and Waist Circumference

    centimetres

    Time frame: 0, 4 and 8 weeks

  14. Body Composition

    Change in body composition via Dual Energy XX-Ray Absorptiometry scan

    Time frame: 0, 4 and 8 weeks

  15. Markers of metabolic health

    mmol/L * Glucose * Non-Esterified Fatty Acids * Triglycerides * Total cholesterol * Low Density Lipoprotein Cholesterol * High Density Lipoprotein Cholesterol

    Time frame: 0, 4 and 8 weeks

07

Study locations

1 of 1 sites recruiting
  • University of Bath
    Bath, BA27AY, United Kingdom
    Recruiting
08

References and documents

Publications

  • Deere R, Farrow M, Spellanzon B, Chowdhury E, Thompson D, Bilzon JLJ. The effects of short-term dietary calorie restriction combined with aerobic exercise on systemic inflammation in overweight or obese individuals with knee osteoarthritis: a randomised controlled trial. Musculoskelet Sci Pract. 2026 Apr;82:103505. doi: 10.1016/j.msksp.2026.103505. Epub 2026 Feb 6. PubMed 41759492 ↗

Study documents

  • Study protocol · Oct 13, 2020
  • Informed consent form · Jan 14, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Anonymous individual data for all outcomes may be made available.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Aug 2023, 19 months after the start.

Of 1,143 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 19 months is close to that.

Counting every sponsor, half of 1,285 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2022
First posted
Aug 29, 2022
StartActual
Jan 1, 2022
Primary completionEst.
Aug 1, 2023
CompletionEst.
Aug 1, 2023
Last update
Aug 29, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05518890
Lead sponsor
University of Bath
Responsible party
James Bilzon (Professor James Bilzon, University of Bath) — Principal investigator
First posted
Aug 29, 2022
Start date
Jan 1, 2022
Primary completion
Aug 1, 2023 (estimated)
Completion
Aug 1, 2023 (estimated)
Last update
Aug 29, 2022

Study contacts

Rachel L Deere, MSc
Contact
r.deere@bath.ac.uk
01225 385918
James Bilzon, PhD
principal investigator · University of Bath

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion